BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35703984)

  • 1. Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study.
    Teo YX; Haw WY; Vallejo A; McGuire C; Woo J; Friedmann PS; Polak ME; Ardern-Jones MR
    Toxicol Sci; 2022 Aug; 189(1):20-31. PubMed ID: 35703984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.
    Cabañas R; Ramírez E; Sendagorta E; Alamar R; Barranco R; Blanca-López N; Doña I; Fernández J; Garcia-Nunez I; García-Samaniego J; Lopez-Rico R; Marín-Serrano E; Mérida C; Moya M; Ortega-Rodríguez NR; Rivas Becerra B; Rojas-Perez-Ezquerra P; Sánchez-González MJ; Vega-Cabrera C; Vila-Albelda C; Bellón T
    J Investig Allergol Clin Immunol; 2020; 30(4):229-253. PubMed ID: 31932268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
    Bedouelle E; Ben Said B; Tetart F; Milpied B; Welfringer-Morin A; Maruani A; Catteau B; Dezoteux F; Staumont-Sallé D; Mazereeuw-Hautier J; Abasq C; Chiaverini C; Delaunay J; Mallet S; Sterling B; Puzenat E; Raynal M; Collet E; Bernier C;
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1):267-274.e5. PubMed ID: 34332174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
    Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
    Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.
    Wolfson AR; Zhou L; Li Y; Phadke NA; Chow OA; Blumenthal KG
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):633-640. PubMed ID: 30176295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility and Safety of Skin Tests in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Systematic Review.
    Teo YX; Friedmann PS; Polak ME; Ardern-Jones MR
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):481-491.e5. PubMed ID: 36154897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
    de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
    Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
    Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
    Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.
    Konvinse KC; Trubiano JA; Pavlos R; James I; Shaffer CM; Bejan CA; Schutte RJ; Ostrov DA; Pilkinton MA; Rosenbach M; Zwerner JP; Williams KB; Bourke J; Martinez P; Rwandamuriye F; Chopra A; Watson M; Redwood AJ; White KD; Mallal SA; Phillips EJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):183-192. PubMed ID: 30776417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
    Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
    Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
    Sarajärvi P; Kubin M; Tasanen K; Huilaja L
    Duodecim; 2017; 133(1):43-51. PubMed ID: 29199808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Drug Hypersensitivity in a Small Child with DRESS Syndrome - A Case Report.
    Gruber S; Gona-Hoepler L; Bangert C; Diesner SC; Schmidthaler K; Szepfalusi Z
    Klin Padiatr; 2023 Jan; 235(1):52-54. PubMed ID: 35785803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
    de Groot AC
    Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
    Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
    Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Presentation and Diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review.
    St George-Hyslop F; Cherepacha N; Chugani B; Alabdeen Y; Sanchez-Espino LF; Mahood Q; Sibbald C; Verstegen RHJ
    Clin Rev Allergy Immunol; 2024 Feb; 66(1):112-123. PubMed ID: 38466562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.